How PIC/S Enhances Joint and Remote GMP Inspections Worldwide
The evolution of pharmaceutical oversight has expanded beyond traditional on-site audits to include joint and remote inspections. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) plays a pivotal role in coordinating these multi-national and virtual inspection models to ensure harmonized GMP compliance. This article explores the role of PIC/S in joint and remote inspections, highlighting benefits, mechanisms, and best practices for pharmaceutical companies operating in an increasingly globalized and digitized environment.
What Are Joint and Remote Inspections?
- Joint Inspections: Conducted simultaneously by two or more regulatory authorities, often from different countries
- Remote Inspections: Conducted partially or fully using digital tools without the need for on-site presence
- Hybrid Inspections: Combine physical and remote elements, especially post-pandemic
- All models aim to enhance regulatory collaboration, reduce duplication, and optimize resources
Why PIC/S Supports These Inspection Models
- Joint and remote inspections align with PIC/S principles of:
- Harmonization
- Mutual confidence
- Inspection reliance
- Enable inspection of shared suppliers, contract manufacturers, and API providers
- Reduce audit fatigue for globally operating pharmaceutical companies
- Enhance inspection capacity in regions with limited resources
PIC/S Mechanisms Enabling Joint Inspections
- Joint Visit Programme (JVP): Trains inspectors by conducting joint inspections with other authorities
- Coordinated Inspection Initiatives: Used for shared facilities that manufacture for
multiple jurisdictions
Technical Working Groups: Define protocols, report formats, and confidentiality agreements
Shared Aide-Memoires: Provide harmonized inspection checklists and deficiency classification standards
How Joint Inspections Are Conducted
- Agencies agree on inspection objectives and roles (e.g., lead and observer inspectors)
- Pre-inspection data (e.g., Site Master File, audit history) shared securely
- Unified inspection plan developed, covering:
- Systems (e.g., QMS, production, stability studies)
- Schedules and shift coverage
- Report compilation responsibilities
- Post-inspection debrief and consolidated report generation
- Findings shared with respective national regulatory agencies
Examples of Joint Inspection Initiatives Under PIC/S
- EMA and US FDA: Joint inspections under Mutual Recognition Agreement (MRA)
- Swissmedic and TGA: Conducted joint inspections for sterile manufacturing sites
- ASEAN regulators: Collaborate using PIC/S templates for vaccine and biosimilar sites
- WHO Prequalification: Leverages PIC/S member reports to avoid duplicative audits
Remote Inspections: Accelerated by the Pandemic
- COVID-19 forced regulators to adopt remote GMP inspections using digital tools
- PIC/S developed guidance for remote GMP inspections in 2021
- Supported by video tours, secure file sharing, and live document reviews
- Includes pre-inspection technical setup meetings and mock runs
Technical Requirements for Remote Inspections
- Reliable internet and video conferencing infrastructure
- Secure document sharing platform (e.g., SharePoint, encrypted Dropbox)
- Dedicated virtual inspection room for live walkthroughs
- Readily accessible electronic SOPs, BMRs, equipment logs, and audit trails
Scope and Limitations of Remote Inspections
- Suitable for:
- Pre-inspection reviews
- Follow-ups or CAPA verification
- Document-based assessments (e.g., quality systems, data integrity)
- Less suitable for:
- Complex sterile operations requiring visual inspection
- Facilities with poor connectivity or lacking digital systems
- May be followed by an on-site visit if needed
Best Practices for Hosting a PIC/S Remote or Joint Inspection
- Prepare a digital inspection package:
- Site Master File, VMP, audit history, org charts
- Key SOPs and training records
- Assign a virtual coordination team:
- Moderator, technical host, SME facilitators, and document runners
- Rehearse document retrieval and system demonstrations
- Ensure virtual room readiness:
- Audio-visual testing
- Clean and labeled equipment
- Schedule breaks, Q&A sessions, and closing meetings
Advantages of PIC/S-Facilitated Inspection Models
- Enhance global cooperation and inspection reliance
- Faster resolution of CAPAs and licensing reviews
- Lower inspection burden on multi-site manufacturers
- More efficient use of regulatory and industry resources
Future of Joint and Remote Inspections in PIC/S
- Expected increase in hybrid inspections across biologics and ATMP facilities
- Expansion of shared inspection platforms and digital data lakes
- Further development of real-time data access models for audit trails and LIMS
- Closer integration with reliance programs under WHO, ICH, and regional blocs
Conclusion
PIC/S has transformed how GMP inspections are conducted by supporting joint and remote models that reflect modern manufacturing realities. These approaches not only reduce regulatory duplication but also foster trust, consistency, and resource efficiency across borders. For pharmaceutical companies, understanding and embracing these inspection models is key to maintaining a globally compliant and inspection-ready operation in the era of harmonized oversight.